Sjögren's syndrome--a plethora of clinical and immunological phenotypes with a complex genetic background - PubMed (original) (raw)
Review
Sjögren's syndrome--a plethora of clinical and immunological phenotypes with a complex genetic background
Roland Jonsson et al. Ann N Y Acad Sci. 2007 Jun.
Abstract
Primary Sjögren's syndrome is a complex autoimmune disorder, considered to represent an ideal disease with which to study the mechanisms underlying autoimmunity because its manifestations are both organ specific and systemic in nature. The characteristic histologic finding in target organs is a progressive focal infiltration of mononuclear lymphoid cells, replacing glandular epithelium (lymphoepithelial lesion). This involvement has been re-emphasized in the 2002 revised EU criteria for Sjögren's syndrome. Moreover, ectopic secondary lymphoid follicles in Sjögren's syndrome contain all elements of relevance for driving an autoimmune response. A number of cytokines and chemokines are involved and particularly B cell activating factor seems to direct the lifespan of infiltrating B cells by enhancing their proliferation and maturation. The recent discovery of clinical benefit after B cell depletion also highlights the pivotal role of B cells in Sjögren's syndrome. A major challenge in Sjögren's syndrome will be to stratify the disease process including genetic and environmental triggers. Identification of novel genetic and molecular markers may lead to the development of better diagnostic and prognostic tools in Sjögren's syndrome including its systemic complications. This minor review will cover the current knowledge on classification, pathogenesis, multiplex findings, potential candidate genes, gene profiling results, and novel therapy approaches. New hypotheses behind the complexity of Sjögren's syndrome are expected to follow.
Similar articles
- The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
Jonsson R, Vogelsang P, Volchenkov R, Espinosa A, Wahren-Herlenius M, Appel S. Jonsson R, et al. Immunol Lett. 2011 Dec 30;141(1):1-9. doi: 10.1016/j.imlet.2011.06.007. Epub 2011 Jul 12. Immunol Lett. 2011. PMID: 21777618 Review. - Disease mechanisms in Sjögren's syndrome: What do we know?
Jonsson R. Jonsson R. Scand J Immunol. 2022 Mar;95(3):e13145. doi: 10.1111/sji.13145. Epub 2022 Feb 1. Scand J Immunol. 2022. PMID: 35073430 Review. - Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG, Yamachika S, Yamamoto H, Maeda N, Nakagawa Y, Peck AB, Robinson CP. Humphreys-Beher MG, et al. Eur J Morphol. 1998 Aug;36 Suppl:247-51. Eur J Morphol. 1998. PMID: 9825931 - Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome.
Dörner T, Lipsky PE. Dörner T, et al. Arthritis Res. 2002;4(6):360-71. doi: 10.1186/ar603. Epub 2002 Sep 25. Arthritis Res. 2002. PMID: 12453312 Free PMC article. Review. - Secondary Sjögren's syndrome--the sausage factory revisited.
Isenberg DA. Isenberg DA. Clin Exp Rheumatol. 1994 Nov-Dec;12 Suppl 11:S19-21. Clin Exp Rheumatol. 1994. PMID: 7768045 Review.
Cited by
- Prevalence and clinical significance of anti-SSA antibody in the Chinese health screening population.
Jia Y, Luan S, Huang S, Zhang W, Li M, Xu T, Fei Y. Jia Y, et al. Clin Exp Immunol. 2024 Oct 16;218(2):169-176. doi: 10.1093/cei/uxae073. Clin Exp Immunol. 2024. PMID: 39136066 Free PMC article. - The Physical and Psychosocial Impact of Fatigue among Patients with Sjogren's Syndrome: A Systematic Review.
Mardale DA, Opriș-Belinski D, Bojincă V, Bojincă M, Mazilu D, Păsăran E, Nițăa C, Groșeanu L, Berghea F, Bălănescu AR. Mardale DA, et al. J Clin Med. 2024 Mar 7;13(6):1537. doi: 10.3390/jcm13061537. J Clin Med. 2024. PMID: 38541763 Free PMC article. Review. - Adipose-derived stem cells postpone the progression of Sjögren's syndrome by upregulating the Hippo signaling pathway.
Li Z, Fan X, Xu X, Zhou Q, Xing G, Liu G. Li Z, et al. Exp Ther Med. 2022 Jul 22;24(3):587. doi: 10.3892/etm.2022.11524. eCollection 2022 Sep. Exp Ther Med. 2022. PMID: 35949326 Free PMC article. - Proteomic Profiling of Saliva and Tears in Radiated Head and Neck Cancer Patients as Compared to Primary Sjögren's Syndrome Patients.
Hynne H, Aqrawi LA, Jensen JL, Thiede B, Palm Ø, Amdal CD, Westgaard KL, Herlofson BB, Utheim TP, Galtung HK. Hynne H, et al. Int J Mol Sci. 2022 Mar 28;23(7):3714. doi: 10.3390/ijms23073714. Int J Mol Sci. 2022. PMID: 35409074 Free PMC article. - Deregulation of the Kallikrein Protease Family in the Salivary Glands of the Sjögren's Syndrome ERdj5 Knockout Mouse Model.
Moustardas P, Yamada-Fowler N, Apostolou E, Tzioufas AG, Turkina MV, Spyrou G. Moustardas P, et al. Front Immunol. 2021 Jul 7;12:693911. doi: 10.3389/fimmu.2021.693911. eCollection 2021. Front Immunol. 2021. PMID: 34305928 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical